Madrigal Pharmaceuticals (MDGL) PT Raised to $620 at H.C. Wainwright
Tweet Send to a Friend
H.C. Wainwright analyst Andrew Fein raised the price target on Madrigal Pharmaceuticals (NASDAQ: MDGL) to $620.00 while maintaining a Buy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
